Peptide record

TPDB03210

Antibacterial Anticancer Antifungal Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03210
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia CAFPdb dbAMP ToxinPred 3.0
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
Sequence
GFCWYVCVYRNGVRVCYRRCN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C115H170N36O27S4
ADEQHILKMPST
RCV
2617.08
9.14
4
0
9
+4
2.14
-0.048
55.24
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
10220
3.91
9
Residue Composition
number
0
A
4
R
2
N
0
D
4
C
0
E
0
Q
2
G
0
H
0
I
0
L
0
K
0
M
1
F
0
P
0
S
0
T
1
W
3
Y
4
V
Amino Acid Distribution
A: 0 R: 4 N: 2 D: 0 C: 4 E: 0 Q: 0 G: 2 H: 0 I: 0 L: 0 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 1 Y: 3 V: 4
Chemical Descriptors
21 reviewed residue count
C115H170N36O27S4 sequence-only estimate (linear, free termini)
2617.08 sequence-only estimate (linear, free termini)
9.14 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
2.14 sequence-only estimate (linear, free termini)
-0.048 sequence-only estimate (linear, free termini)
Evidence Records 8 records
Evidence 1 Activity

Activity

4.4±1.1% Hemolysis
Toxicity
300 µg/mL
Hemolytic Cytotoxic
4.4±1.1% Hemolysis | 300 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides. | ACS Infect Dis | 2016
Evidence 2 Activity

Activity

50% Cell death
Toxicity
271 µg/mL
Cytotoxic
50% Cell death | 271 | µg/mL | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria. | Nat Commun | 2020
Evidence 3 Activity

Activity

50% Cell death
Toxicity
170 µg/mL
Cytotoxic
50% Cell death | 170 | µg/mL | target cell: Human kidney proximal tubule HK-2 cells

Target

Human kidney proximal tubule HK-2 cells

Source & Reference

NA
DBAASP
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria. | Nat Commun | 2020
Evidence 4 Activity

Activity

10% Hemolysis
Toxicity
204 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 204 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria. | Nat Commun | 2020
Evidence 5 Activity

Activity

20% Hemolysis
Toxicity
1.2 ± 1 µg/mL
Hemolytic Cytotoxic
20% Hemolysis | 1.2 ± 1 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Investigations into the membrane activity of arenicin antimicrobial peptide AA139. | Biochim Biophys Acta | 2022
Evidence 6 Activity

Activity

50% Cytotoxicity
Toxicity
104.6 ± 1.8 µg/mL
Cytotoxic
50% Cytotoxicity | 104.6 ± 1.8 | µg/mL | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Investigations into the membrane activity of arenicin antimicrobial peptide AA139. | Biochim Biophys Acta | 2022
Evidence 7 Activity

Activity

50% Cytotoxicity
Toxicity
>100 µM
Cytotoxic
50% Cytotoxicity | >100 | µM | target cell: Human bronchial epithelial cells BEAS-2B

Target

Human bronchial epithelial cells BEAS-2B

Source & Reference

NA
DBAASP
Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessus | J Biomed Sci | 2024
Evidence 8 Activity

Activity

50% Hemolysis
Toxicity
>100 µM
Hemolytic Cytotoxic
50% Hemolysis | >100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessus | J Biomed Sci | 2024